GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fees and other income is the income earned by insurance companies other than providing insurances. GlaxoSmithKline PLC's fees and other income for the three months ended in Dec. 2013 was $11,377 Mil. Its fees and other income for the trailing twelve months (TTM) ended in Dec. 2013 was $41,812 Mil.
GlaxoSmithKline PLC's quarterly fees and other income increased from Jun. 2013 ($10,042 Mil) to Sep. 2013 ($10,483 Mil) and increased from Sep. 2013 ($10,483 Mil) to Dec. 2013 ($11,377 Mil).
GlaxoSmithKline PLC's annual fees and other income declined from Dec. 2011 ($42,526 Mil) to Dec. 2012 ($42,222 Mil) but then increased from Dec. 2012 ($42,222 Mil) to Dec. 2013 ($43,666 Mil).
Income earned by insurance companies other than providing insurances. It includes investing income, fees and interest income.
GlaxoSmithKline PLC Fees and Other Income for the trailing twelve months (TTM) ended in Dec. 2013 was 9909.64777948 (Mar. 2013 ) + 10042.4886191 (Jun. 2013 ) + 10483.0917874 (Sep. 2013 ) + 11377.2652389 (Dec. 2013 ) = $41,812 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data